flucytosine has been researched along with Sarcoidosis, Pulmonary in 3 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marie, I | 1 |
Cheriet, S | 1 |
Assie, C | 1 |
Etienne, M | 1 |
Favennec, L | 1 |
Baallal, H | 1 |
El Asri, AC | 1 |
Eljebbouri, B | 1 |
Akhaddar, A | 1 |
Gazzaz, M | 1 |
El Mostarchid, B | 1 |
Boucetta, M | 1 |
Cancelli, I | 1 |
Merlino, G | 1 |
Serafini, A | 1 |
Valente, M | 1 |
Gigli, GL | 1 |
3 other studies available for flucytosine and Sarcoidosis, Pulmonary
Article | Year |
---|---|
Cryptococcosis in sarcoidosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Hu | 2010 |
[Cryptococcal meningitis in a patient with a ventriculoperitoneal shunt and monitoring for pulmonary sarcoidosis].
Topics: Amphotericin B; Antifungal Agents; Arachnoiditis; Carbon; Cerebrospinal Fluid; Coloring Agents; Conf | 2013 |
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fatal Outcome; Flucytosine; Human | 2008 |